Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/21128
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | MIOSSI, Renata | - |
dc.contributor.author | SOUZA, Fernando Henrique Carlos de | - |
dc.contributor.author | SHINJO, Samuel Katsuyuki | - |
dc.date.accessioned | 2017-08-01T15:16:01Z | - |
dc.date.available | 2017-08-01T15:16:01Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | MEDICALEXPRESS, v.4, n.2, 2017 | - |
dc.identifier.issn | 2358-0429 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/21128 | - |
dc.description.abstract | OBJECTIVES: To evaluate serum levels of C-reactive protein and erythrocyte sedimentation rates in patients with untreated newly diagnosed dermatomyositis or polymyositis and their correlation with clinical and laboratory parameters. METHODS: A cross-sectional study including 48 consecutive patients with untreated newly diagnosed dermatomyositis and polymyositis reviewed between 2002 and 2015 was conducted. Fifty healthy subjects were enrolled as controls. RESULTS: Patients with dermatomyositis and polymyositis had higher levels of C-reactive protein and erythrocyte sedimentation rate than healthy controls, but these values were not associated with clinical or laboratory parameters of disease activity either for dermatomyositis or for polymyositis. Additionally, erythrocyte sedimentation rate values correlated with pulmonary involvement as evidenced through computer tomography imaging (OR 1.15; 95%CI 1.01-1.31) only in patients with polymyositis. CONCLUSIONS: Although elevated, C-reactive protein and erythrocyte sedimentation rate are not sensitive parameters for measuring clinical and laboratory activity of dermatomyositis nor for polymiositis. However, erythrocyte sedimentation rate may be a valid parameter for screening pulmonary involvement, particularly in patients with polymyositis. | - |
dc.description.abstract | OBJETIVOS: Avaliar os níveis séricos da proteína C reativa (PCR) e da velocidade de hemossedimentação (VHS) em pacientes recém-diagnosticados com dermatomiosite (DM) e polimiosite (PM), sem tratamento prévio, correlacionando-os com parâmetros clínico-laboratoriais. MÉTODOS: Estudo transversal que incluiu 48 pacientes consecutivos com DM e PM (critérios de Bohan e Peter) recém-diagnosticados, sem tratamento medicamentoso, no período de 2002 a 2015. Foram incluídos 50 indivíduos saudáveis como grupo controle. RESULTADOS: Os pacientes apresentaram níveis mais elevados de VHS e PCR comparativamente aos controles saudáveis. Estes valores, porém, não se correlacionaram com os parâmetros clínicos e laboratoriais da atividade da doença (DM e PM). Somente em pacientes com PM a VHS apresentou relação com acometimento pulmonar na tomografia computadorizada [OR 1,15 (IC 95% 1,01-1,31)]. CONCLUSÕES: Apesar de aumentadas, a PCR e a VHS não são parâmetros sensíveis para a mensuração da atividade clínica e laboratorial de DM e PM., No entanto, a VHS pode ter validade no rastreio do acometimento pulmonar, particularmente em pacientes com PM. | - |
dc.language.iso | eng | - |
dc.publisher | Mavera Edições Técnicas e Científicas Ltda | - |
dc.relation.ispartof | MedicalExpress | - |
dc.rights | openAccess | - |
dc.subject | Dermatomyositis | - |
dc.subject | polymyositis | - |
dc.subject | C-reactive protein | - |
dc.subject | erythrocyte sedimentation rate | - |
dc.subject | Dermatomiosite | - |
dc.subject | polimiosite | - |
dc.subject | proteína C reativa | - |
dc.subject | velocidade de hemossedimentação | - |
dc.title | Could C-reactive protein and erythrocyte sedimentation rate support monitoring of dermatomyositis and polymyositis activity? | - |
dc.title.alternative | É POSSÍVEL SUPOR QUE A PROTEÍNA C REATIVA E A HEMOSSEDIMENTAÇÃO POSSAM SER USADAS PARA MONITORAR A ATIVIDADE DA DERMATOMIOSITE E DA POLIMIOSITE? | - |
dc.type | article | - |
dc.rights.holder | Copyright Mavera Edições Técnicas e Científicas Ltda | - |
dc.identifier.doi | 10.5935/medicalexpress.2017.02.05 | - |
dc.subject.wos | Health Care Sciences & Services | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.issue | 2 | - |
hcfmusp.description.volume | 4 | - |
hcfmusp.origem | sciELO | - |
hcfmusp.origem.id | SCIELO:S2358-04292017000200004 | - |
hcfmusp.relation.reference | Amerio P, 2002, EUR J DERMATOL, V12, P165 | - |
hcfmusp.relation.reference | BASSETSEGUIN N, 1990, ARCH DERMATOL, V126, P633, DOI 10.1001/archderm.126.5.633 | - |
hcfmusp.relation.reference | Bohan A, 1975, N Engl J Med, V292, P344 | - |
hcfmusp.relation.reference | Briani C, 2006, AUTOIMMUNITY, V39, P161, DOI 10.1080/08916930600622132 | - |
hcfmusp.relation.reference | Brigden ML, 1999, AM FAM PHYSICIAN, V60, P1443 | - |
hcfmusp.relation.reference | Burnouf M, 2003, ANN DERMATOL VENER, V130, P313 | - |
hcfmusp.relation.reference | Chen D, 2014, CLIN EXP RHEUMATOL, V32, P615 | - |
hcfmusp.relation.reference | Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x | - |
hcfmusp.relation.reference | Dalakas MC, 2015, NEW ENGL J MED, V373, P393, DOI 10.1056/NEJMc1506827 | - |
hcfmusp.relation.reference | Dalakas MC, 2015, NEW ENGL J MED, V372, P1734, DOI 10.1056/NEJMra1402225 | - |
hcfmusp.relation.reference | Di Rollo D, 2014, GIORN ITAL DERMAT V, V149, P525 | - |
hcfmusp.relation.reference | Diaz MTM, 2017, J Bras Patol Med Lab | - |
hcfmusp.relation.reference | GABAY C, 1994, ARTHRITIS RHEUM, V37, P1744, DOI 10.1002/art.1780371206 | - |
hcfmusp.relation.reference | Go DJ, 2016, J KOREAN MED SCI, V31, P389, DOI [10.3346/jkms.2016.31.3.389, 10.3346/jkms.2016.31.3.339] | - |
hcfmusp.relation.reference | Ideura G, 2007, RESP MED, V101, P1406, DOI 10.1016/j.rmed.2007.01.023 | - |
hcfmusp.relation.reference | [林辉 Lin Hui], 2013, [四川大学学报. 医学版, Journal of Sichuan University. Medical Science Edition], V44, P805 | - |
hcfmusp.relation.reference | MALLYA RK, 1982, J RHEUMATOL, V9, P224 | - |
hcfmusp.relation.reference | Marie I, 2002, ARTHRIT RHEUM-ARTHR, V47, P614, DOI 10.1002/art.10794 | - |
hcfmusp.relation.reference | Park JK, 2013, RHEUMATOLOGY, V52, P1336, DOI 10.1093/rheumatology/ket162 | - |
hcfmusp.relation.reference | Cruellas Marcela Gran Pina, 2013, Clinics, V68, P909, DOI 10.6061/clinics/2013(07)04 | - |
hcfmusp.relation.reference | Pinhata MM, 2015, CLIN EXP RHEUMATOL, V33, P310 | - |
hcfmusp.relation.reference | Rider LG, 2004, ARTHRITIS RHEUM, V50, P2281, DOI 10.1002/art.20349 | - |
hcfmusp.relation.reference | Rider Lisa G., 2003, Journal of Rheumatology, V30, P603 | - |
hcfmusp.relation.reference | Shinjo SK, 2015, CLIN EXP RHEUMATOL, V33, P336 | - |
hcfmusp.relation.reference | Souza Fernando Henrique Carlos de, 2011, Rev Bras Reumatol, V51, P428 | - |
hcfmusp.relation.reference | Souza FH, 2012, Rev Bras Reumatol, V52, P897 | - |
hcfmusp.relation.reference | Sparsa A, 2002, ARCH DERMATOL, V138, P885, DOI 10.1001/archderm.138.7.885 | - |
hcfmusp.relation.reference | Sun YC, 2013, RHEUMATOL INT, V33, P1295, DOI 10.1007/s00296-012-2545-7 | - |
hcfmusp.relation.reference | Tanaka A, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0547-z | - |
hcfmusp.relation.reference | Ye S, 2007, CLIN RHEUMATOL, V26, P1647, DOI 10.1007/s10067-007-0562-9 | - |
dc.description.index | SciELO | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/17 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_MIOSSI_Could_Creactive_protein_and_erythrocyte_sedimentation_rate_support_2017.PDF | publishedVersion (English) | 285.87 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.